The international independent ranking organisation AD Scientific Index is more than an ordinary "Ranking". The "AD Scientific Index" analyses the academic work of scientists using the H-index, i10 index and number of citations, and provides results that can be used to evaluate the productivity and efficiency of individuals and institutions. In addition to ranking according to "total H-index" for individuals and institutions, you can also see the ranking and analyses according to "last 6 years H-index", "total i10 Productivity index", "last 6 years i10 Productivity index", "total citations" and "last 6 years citations" only in "AD Scientific Index". See also: Subject Rankings and University Subject Rankings. Click here for individual or institutional registration.
AD Scientific Index - World Scientists Rankings - 2024 | H INDEX | i10 INDEX | CITATION | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
University / Institution |
Country | Region | World | Name | Country | University / Institution | Subject | Total | Last 6 year | Last 6 year/total | Total | Last 6 year | Last 6 year/total | Total | Last 6 year | Last 6 year/total |
7 | 12,998 | 14,373 | 30,673 |
|
United States | Regeneron Pharmaceuticals Inc |
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
Respiratory drug development | clinical trials | |
69 | 53 | 0.768 | 156 | 138 | 0.885 | 31,595 | 21,386 | 0.677 |
8 | 16,547 | 18,371 | 40,189 |
|
United States | Regeneron Pharmaceuticals Inc |
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
Asthma | genetics | |
63 | 54 | 0.857 | 126 | 104 | 0.825 | 60,820 | 28,646 | 0.471 |
9 | 23,283 | 26,008 | 59,165 |
|
United States | Regeneron Pharmaceuticals Inc |
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
biotechnology | genetics | clinical trials | |
55 | 52 | 0.945 | 108 | 100 | 0.926 | 14,606 | 13,517 | 0.925 |
17 | 64,416 | 72,878 | 198,100 |
|
United States | Regeneron Pharmaceuticals Inc |
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
clinical pharmacology | monoclonal antibodies | drug-drug interactions | pharmacokinetics/pharmacodynamics | |
33 | 24 | 0.727 | 71 | 44 | 0.620 | 7,421 | 5,798 | 0.781 |
19 | 64,861 | 73,397 | 199,806 |
|
United States | Regeneron Pharmaceuticals Inc |
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
HEOR | |
33 | 22 | 0.667 | 72 | 43 | 0.597 | 3,244 | 1,655 | 0.510 |
28 | 91,738 | 103,839 | 302,109 |
|
United States | Regeneron Pharmaceuticals Inc |
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
asthma | urticaria | pediatrics | nasal polyps | food allergy | |
26 | 21 | 0.808 | 50 | 44 | 0.880 | 2,303 | 1,829 | 0.794 |
31 | 97,262 | 110,097 | 323,765 |
|
United States | Regeneron Pharmaceuticals Inc |
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
Molecular Imaging | Antibody-based therapeutics | immunoPET | Targeted Radiotherapy | Cancer Biology | |
25 | 20 | 0.800 | 37 | 31 | 0.838 | 1,668 | 1,263 | 0.757 |
33 | 103,275 | 116,878 | 347,536 |
|
United States | Regeneron Pharmaceuticals Inc |
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
Quantitative Clinical Pharmacology | Clinical Pharmacometrics | Statistics | Drug Development | Clinical | |
24 | 18 | 0.750 | 44 | 35 | 0.795 | 2,103 | 1,374 | 0.653 |
36 | 109,403 | 123,755 | 371,174 |
|
United States | Regeneron Pharmaceuticals Inc |
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
Biotherapeutic Protein/AAV Characterization | LC-MS/MS | Bottom-Up Proteomics | Target Proteomics | |
23 | 18 | 0.783 | 27 | 23 | 0.852 | 2,655 | 1,421 | 0.535 |
37 | 110,329 | 124,798 | 375,426 |
|
United States | Regeneron Pharmaceuticals Inc |
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
Anti-cancer antibodies and cancer immunotherapy | |
23 | 16 | 0.696 | 31 | 18 | 0.581 | 1,624 | 800 | 0.493 |
Click for INSTITUTIONAL BULK REGISTRATION and PREMIUM MEMBERSHIP advantages |
||||||||||||||||
46 | 121,444 | 137,248 | 418,479 |
|
United States | Regeneron Pharmaceuticals Inc |
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
Clinical Pharmacology | Pharmacokinetics | Drug-Drug Interactions | Biologics | |
21 | 18 | 0.857 | 33 | 24 | 0.727 | 2,654 | 1,849 | 0.697 |
52 | 125,471 | 141,799 | 435,038 |
|
United States | Regeneron Pharmaceuticals Inc |
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
Diabetes | Obesity | Metabolism | |
21 | 12 | 0.571 | 26 | 17 | 0.654 | 2,615 | 667 | 0.255 |
54 | 128,827 | 145,527 | 447,237 |
|
United States | Regeneron Pharmaceuticals Inc |
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
Bone Metastasis | Cancer | |
20 | 18 | 0.900 | 22 | 20 | 0.909 | 1,935 | 957 | 0.495 |
56 | 136,523 | 154,139 | 478,917 |
|
United States | Regeneron Pharmaceuticals Inc |
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
Host Microbial relationships | |
19 | 17 | 0.895 | 23 | 20 | 0.870 | 3,438 | 2,900 | 0.844 |
60 | 140,382 | 158,448 | 494,745 |
|
United States | Regeneron Pharmaceuticals Inc |
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
Bioanalysis | LC-MS | Biotherapeutics | Biomarker | GLP | |
19 | 13 | 0.684 | 22 | 17 | 0.773 | 1,338 | 428 | 0.320 |
66 | 158,739 | 178,922 | 568,045 |
|
United States | Regeneron Pharmaceuticals Inc |
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
Neurobiology | Neurodegeneration | Multiple Sclerosis | Progression | Alzheimer's Disease | |
17 | 12 | 0.706 | 19 | 14 | 0.737 | 1,388 | 708 | 0.510 |
68 | 159,307 | 179,563 | 570,962 |
|
United States | Regeneron Pharmaceuticals Inc |
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
NMR | MRS | MRI | |
17 | 11 | 0.647 | 21 | 14 | 0.667 | 752 | 379 | 0.504 |
78 | 179,797 | 202,256 | 652,284 |
|
United States | Regeneron Pharmaceuticals Inc |
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
immuno-oncology | cancer biology | stress response pathways | |
15 | 11 | 0.733 | 16 | 12 | 0.750 | 1,594 | 757 | 0.475 |
81 | 182,717 | 205,476 | 664,934 |
|
United States | Regeneron Pharmaceuticals Inc |
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
Precision Medicine | Clinical AI/ML | Digital Health Technology | Clinical Research | Biomarkers | |
14 | 14 | 1.000 | 20 | 20 | 1.000 | 1,290 | 1,092 | 0.847 |
87 | 190,210 | 213,784 | 694,559 |
|
United States | Regeneron Pharmaceuticals Inc |
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
Human disease and therapeutics | |
14 | 11 | 0.786 | 15 | 11 | 0.733 | 1,187 | 702 | 0.591 |
92 | 195,916 | 220,107 | 719,028 |
|
United States | Regeneron Pharmaceuticals Inc |
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
Muscle Biology | Metabolism | |
13 | 13 | 1.000 | 14 | 14 | 1.000 | 535 | 530 | 0.991 |
96 | 198,180 | 222,580 | 727,832 |
|
United States | Regeneron Pharmaceuticals Inc |
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
Acute kidney injury | Chronic kidney disease | diabetic nephropathy | renal fibrosis | glomerulopathies | |
13 | 12 | 0.923 | 14 | 13 | 0.929 | 952 | 538 | 0.565 |
100 | 201,426 | 226,161 | 741,307 |
|
United States | Regeneron Pharmaceuticals Inc |
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
Pharmacoepidemiology | |
13 | 10 | 0.769 | 17 | 10 | 0.588 | 858 | 230 | 0.268 |
106 | 218,901 | 245,536 | 816,947 |
|
United States | Regeneron Pharmaceuticals Inc |
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
Computational Genetics | Infectious Diseases | |
11 | 11 | 1.000 | 13 | 13 | 1.000 | 1,394 | 1,336 | 0.958 |
111 | 223,333 | 250,419 | 835,940 |
|
United States | Regeneron Pharmaceuticals Inc |
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
Huntington's disease | Parkinson's disease | |
11 | 10 | 0.909 | 12 | 11 | 0.917 | 407 | 373 | 0.916 |